Drug Discovery 2018
London, UK (March, 21 - 22, 2018)
The pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently, the event will focus on key developments in this very industry.
SMi’s 2nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery, CRISPR and PROTAC’s, as well as discussing advancements in medicinal chemistry, translational medicine and 3D structure based-discovery.
A selection of organisations speaking at this year’s conference include AbbVie, Exscientia, GSK, Roche Pharmaceuticals, MedImmune, Epizyme and many more!
Early bird discounts!
Register by the 30th November to save ?400
15th December to save ?200
31st January to save ?100
Register online at: http://www.drug-discovery.co.uk/G2B
For more information please contact: +44 (0) 207 827 6020 or email: nboumediene@smi-online.co.uk
